Is Buying ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) Here Good Idea?

May 17, 2018 - By Clifton Ray

The stock of ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) registered a decrease of 18.87% in short interest. ASNB’s total short interest was 12,900 shares in May as published by FINRA. Its down 18.87% from 15,900 shares, reported previously. With 105,000 shares average volume, it will take short sellers 0 days to cover their ASNB’s short positions.

The stock increased 17.27% or $0.00518 during the last trading session, reaching $0.03518. About shares traded. AdvanSource Biomaterials Corporation (OTCMKTS:ASNB) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. The company has market cap of $756,039. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. It currently has negative earnings. The firm also makes specialty hydrophilic polyurethanes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.